Soon-Shiong’s NantCell gets $30 million from Celgene
January 07, 2019 at 15:36 PM EST
NantCell, a cancer treatment company founded by biotech entrepreneur Dr. Patrick Soon-Shiong, has received an additional $30 million investment from drug maker Celgene Corp.